Literature DB >> 22541696

Drug-induced liver disease.

Timothy J Davern1.   

Abstract

Drug-induced liver injury (DILI), also known as hepatotoxicity, refers to liver injury caused by drugs or other chemical agents, and represents a special type of adverse drug reaction. It has been estimated that more than 600 drugs and chemicals have been associated with significant liver injury. Many previous reviews have focused on DILI pathogenesis or have outlined the clinical features of liver injury linked to different drugs. This article briefly touches on several areas that are potentially vexing for both the novice and cognoscenti, with the goal of guiding the consultant through one of the most challenging areas of hepatology.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541696     DOI: 10.1016/j.cld.2012.03.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  12 in total

1.  Differential hepatoprotective role of the cannabinoid CB1 and CB2 receptors in paracetamol-induced liver injury.

Authors:  Patricia Rivera; Antonio Vargas; Antoni Pastor; Anna Boronat; Antonio Jesús López-Gambero; Laura Sánchez-Marín; Dina Medina-Vera; Antonia Serrano; Francisco Javier Pavón; Rafael de la Torre; Ekaitz Agirregoitia; María Isabel Lucena; Fernando Rodríguez de Fonseca; Juan Decara; Juan Suárez
Journal:  Br J Pharmacol       Date:  2020-04-15       Impact factor: 8.739

Review 2.  N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review.

Authors:  Mohamed Farouk Chughlay; Nicole Kramer; C Wendy Spearman; Mahmoud Werfalli; Karen Cohen
Journal:  Br J Clin Pharmacol       Date:  2016-03-02       Impact factor: 4.335

3.  A logistic regression model based on inpatient health records to predict drug-induced liver injury caused by ramipril-An angiotensin-converting enzyme inhibitor.

Authors:  Phuong Nguyen Thi Thu; Mai Ngo Thi Quynh; Hung Nguyen Van; Hoi Nguyen Thanh; Khue Pham Minh
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

4.  DILI: New Insights into Diagnosis and Management.

Authors:  Thanh Tran; William M Lee
Journal:  Curr Hepat Rep       Date:  2013-03-01

Review 5.  [Abnormal liver function tests in the intensive care unit].

Authors:  A Koch; K Streetz; J Tischendorf; C Trautwein; F Tacke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-10       Impact factor: 0.840

6.  I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer.

Authors:  Rong Lin; Omar Banafea; Jin Ye
Journal:  BMC Gastroenterol       Date:  2015-05-07       Impact factor: 3.067

7.  N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol.

Authors:  Mohamed Farouk Chughlay; Nicole Kramer; Mahmoud Werfalli; Wendy Spearman; Mark Emmanuel Engel; Karen Cohen
Journal:  Syst Rev       Date:  2015-06-12

8.  Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver.

Authors:  Patricia Rivera; Antoni Pastor; Sergio Arrabal; Juan Decara; Antonio Vargas; Laura Sánchez-Marín; Francisco J Pavón; Antonia Serrano; Dolores Bautista; Anna Boronat; Rafael de la Torre; Elena Baixeras; M Isabel Lucena; Fernando R de Fonseca; Juan Suárez
Journal:  Front Pharmacol       Date:  2017-10-06       Impact factor: 5.810

9.  AMPK Activation Prevents and Reverses Drug-Induced Mitochondrial and Hepatocyte Injury by Promoting Mitochondrial Fusion and Function.

Authors:  Sun Woo Sophie Kang; Ghada Haydar; Caitlin Taniane; Geoffrey Farrell; Irwin M Arias; Jennifer Lippincott-Schwartz; Dong Fu
Journal:  PLoS One       Date:  2016-10-28       Impact factor: 3.240

10.  Field evaluation of a prototype paper-based point-of-care fingerstick transaminase test.

Authors:  Nira R Pollock; Sarah McGray; Donn J Colby; Farzad Noubary; Huyen Nguyen; The Anh Nguyen; Sariah Khormaee; Sidhartha Jain; Kenneth Hawkins; Shailendra Kumar; Jason P Rolland; Patrick D Beattie; Nguyen V Chau; Vo M Quang; Cori Barfield; Kathy Tietje; Matt Steele; Bernhard H Weigl
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.